Centice Corporation Releases Update for the PINPOINT Rx™ Drug Identification System
(PR Web Via Acquire Media NewsEdge) Morrisville, N.C. (PRWEB) June 09, 2011
Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, announced today the release of a new update for PINPOINT Rx™, a low cost device for identifying prescription medications in hospital emergency rooms and patient admission areas.
PINPOINT Rx™ chemically identifies in 10 seconds unknown prescription drugs in oral solid form, as they are introduced into emergency rooms. The analysis and extensive documentation of each pill scan, including date and time, and pill image, is captured and electronically communicated. PINPOINT Rx™ uses Raman spectroscopy, vision and a built in Medi-Span® database to perform the identification.
The PINPOINT Rx™ update contains two new features, a Search Database operation mode, as well as a print feature.
Search Database mode allows users to search Centice’s proprietary library and built in database for prescription drugs based on imprints. A new virtual keyboard, built into the existing touch screen, allows users to easily search for the identification of an unknown prescription drug by imprint or markings. The new print feature allows users to print the identification result information for record keeping or for admittance in a patient chart. After the unknown prescription drug has been identified, the print option will appear and users can enter comments, such as, patient name, identification number, or other important information before printing.
“We are very excited about our continuing efforts to provide a unique solution for emergency room medication reconciliation with PINPOINT Rx™,” said Centice CEO Scott Albert. “These new features should allow medical practitioners to more easily and quickly determine the identification of unknown prescription drugs or pills, and then easily print or store the information.”
Centice recently conducted a market research survey with hospital emergency room and pharmacy personnel about the drug identification process within their hospitals. The results from the market research survey show that over 60% of unknown pills are sent to the pharmacy for identification and it can take hours for the physician and nurses to obtain those results.
Centice Corporation creates and delivers advanced technology innovations to select markets in pharmacy operations, healthcare, manufacturing and homeland security. By leveraging an expertise in applied Raman Spectroscopy, computational sensors, and machine vision technology, Centice provides products and integration expertise that saves lives and protects people’s lifestyles. PINPOINT Rx™ chemically identifies and PASS Rx® chemically verifies prescription medications and are vital components of hospital and pharmacy operations. The company’s scientists and engineering teams work with a network of partners to answer emerging commercial needs. Headquartered in Morrisville, N.C. and founded in 2004, the company maintains sales offices across the country and markets and sells products directly and through distributors. More information can be found at http://www.centice.com.
Read the full story at http://www.prweb.com/releases/2011/6/prweb8553672.htm
(c) 2011 PRWEB.COM Newswire
[ Back To SIP Trunking Home's Homepage ]